Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients

Abstract

Patients with psoriasis are often affected by comorbidities, which largely influence treatment decisions. Here we performed conjoint analysis to assess the impact of comorbidities on preferences of patients with moderate-to-severe psoriasis for outcome (probability of 50% and 90% improvement, time until response, sustainability of success, probability of… (More)
DOI: 10.1371/journal.pone.0144335

Topics

4 Figures and Tables

Cite this paper

@inproceedings{Schaarschmidt2015PatientPF, title={Patient Preferences for Biologicals in Psoriasis: Top Priority of Safety for Cardiovascular Patients}, author={M. L. Schaarschmidt and Christian Kromer and Raphael M Herr and Astrid Schmieder and Diana Sonntag and Sergij Goerdt and Wiebke Katharina Peitsch and Reza Khodarahmi}, booktitle={PloS one}, year={2015} }